GPCR
Structure Therapeutics Inc. American Depositary Shares
NASDAQ: GPCR · HEALTHCARE · BIOTECHNOLOGY
$38.32
-3.79% today
Updated 2026-06-05
Market cap
$3.05B
P/E ratio
—
P/S ratio
—
EPS (TTM)
$-2.64
Dividend yield
—
52W range
$16 – $95
Volume
0.8M
WallStSmart proprietary scores
30
out of 100
Grade: F
Strong Sell
Investment rating
4.3
Growth
C8.5
Quality
A3.0
Profitability
D5.0
Valuation
C+3/9
Piotroski F-Score
Weak
13.9
Altman Z-Score
Safe zone
—
Industry rank
—
View all highly rated stocks (75+) →199 stocks currently score above 75
Price targets
Analyst target
$104.59
+172.94%
12-Month target
—
—
Intrinsic (DCF)
—
Margin of safety
—
4 Strong Buy11 Buy1 Hold0 Sell0 Strong Sell
Price chart
Stock snapshot
Strengths
+ Altman Z 13.90 — safe zone
+ Free cash flow $14.09M — positive
+ Debt/equity 0.00x — low leverage
Risks
- Piotroski 3/9 — weak financial health
- Thin margins at 0.00%
Key financials
Revenue Net Income Free Cash Flow
| Metric | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Revenue | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Net income | $-51.32M | $-89.62M | $-122.53M | $-141.20M | $-76.19M |
| EPS | — | — | — | — | $-2.64 |
| Free cash flow | $-46.27M | $-81.66M | $-117.93M | $-225.81M | $14.09M |
| Profit margin | — | — | — | — | — |
Peer comparison
Smart narrative
Structure Therapeutics Inc. American Depositary Shares trades at $38.32. Our Smart Value Score of 30/100 indicates the stock is weak. The company scores 3/9 on the Piotroski F-Score. With an Altman Z-Score of 13.90, it sits in the safe zone.
Frequently asked questions
What is Structure Therapeutics Inc. American Depositary Shares's stock price?
Structure Therapeutics Inc. American Depositary Shares (GPCR) trades at $38.32.
Is Structure Therapeutics Inc. American Depositary Shares overvalued?
Structure Therapeutics Inc. American Depositary Shares carries a Smart Value Score of 30/100 (Grade F), which we rate Strong Sell. That score blends growth, quality, and valuation into one read.
What is the price target of Structure Therapeutics Inc. American Depositary Shares (GPCR)?
The 12-month analyst consensus target is $104.59, about 172.9% above the current $38.32. A consensus target is the average of Wall Street's 12-month forecasts, so it works as a sentiment gauge rather than a guarantee, and it resets with every earnings cycle.
Altman Z-Score?
Structure Therapeutics Inc. American Depositary Shares's Altman Z-Score is 13.90, which places it in the safe zone. The Altman Z-Score gauges bankruptcy risk from profitability, leverage, and asset efficiency, and a higher reading points to lower financial distress risk.
Company info
SectorHEALTHCARE
IndustryBIOTECHNOLOGY
CountryUSA
ExchangeNASDAQ
CurrencyUSD
Quick metrics
P/S ratio—
ROE-11.90%
Beta-1.42
50D MA$43.50
200D MA$47.72
Shares out0.07B
Float0.05B
Short ratio—
Avg volume0.8M
Performance
1 week—
1 month—
3 months—
YTD—
1 year—
3 years—
5 years—